Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, Wěi Li et al.|New England Journal of Medicine|2022Cited by 2.5k
Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancerMasako Nakamura, Yataro Daigo, Atsushi Takano et al.|International Journal of Oncology|2020Cited by 61
CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancersYoshihiro Mezawa, Akira Orimo, Yataro Daigo et al.|Cancer Medicine|2019Cited by 60
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Noriko Gotoh, Tatsunori Nishimura et al.|Journal of Clinical Investigation|2023Cited by 29
Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblastsYoshihiro Mezawa, Akira Orimo, Tingwei Wang et al.|Cancer Science|2023Cited by 12